The drug, reproxalap, led to reductions in symptoms of dry eye, but regulators have repeatedly refused to approve it for this condition.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/dry-eye-drug-does-well-study-fda-remains-unconvinced-2026a1000c9c?src=rss
Author :
Publish date : 2026-04-20 07:14:00
Copyright for syndicated content belongs to the linked Source.